PPTPP: a novel therapeutic peptide prediction method using physicochemical property encoding and adaptive feature representation learning

iAIPs: Identifying Anti-Inflammatory Peptides Using Random Forest

Recently, several anti-inflammatory peptides (AIPs) have been found in the process of the inflammatory response, and these peptides have been used to treat some inflammatory and autoimmune diseases. Therefore, identifying AIPs accurately from a given amino acid sequences is critical for the discovery of novel and efficient anti-inflammatory peptide-based therapeutics and the acceleration of their application in therapy. In this paper, a random forest-based model called iAIPs for identifying AIPs is proposed. First, the original samples were encoded with three feature extraction methods, including g-gap dipeptide composition (GDC), dipeptide deviation from the expected mean (DDE), and amino acid composition (AAC). Second, the optimal feature subset is generated by a two-step feature selection method, in which the feature is ranked by the analysis of variance (ANOVA) method, and the optimal feature subset is generated by the incremental feature selection strategy. Finally, the optimal feature subset is inputted into the random forest classifier, and the identification model is constructed. Experiment results showed that iAIPs achieved an AUC value of 0.822 on an independent test dataset, which indicated that our proposed model has better performance than the existing methods. Furthermore, the extraction of features for peptide sequences provides the basis for evolutionary analysis. The study of peptide identification is helpful to understand the diversity of species and analyze the evolutionary history of species.

StackDPPIV: A novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides

The development of efficient and effective bioinformatics tools and pipelines for identifying peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activities from large-scale protein datasets is of great importance for the discovery and development of potential and promising antidiabetic drugs. In this study, we present a novel stacking-based ensemble learning predictor (termed StackDPPIV) designed for identification of DPP-IV inhibitory peptides. Unlike the existing method, which is based on single-feature-based methods, we combined five popular machine learning algorithms in conjunction with ten different feature encodings from multiple perspectives to generate a pool of various baseline models. Subsequently, the probabilistic features derived from these baseline models were systematically integrated and deemed as new feature representations. Finally, in order to improve the predictive performance, the genetic algorithm based on the self-assessment-report was utilized to determine a set of informative probabilistic features and then used the optimal one for developing the final meta-predictor (StackDPPIV). Experiment results demonstrated that StackDPPIV could outperform its constituent baseline models on both the training and independent datasets. Furthermore, StackDPPIV achieved an accuracy of 0.891, MCC of 0.784 and AUC of 0.961, which were 9.4%, 19.0% and 11.4%, respectively, higher than that of the existing method on the independent test. Feature analysis demonstrated that our feature representations had more discriminative ability as compared to conventional feature descriptors, which highlights the combination of different features was essential for the performance improvement. In order to implement the proposed predictor, we had built a user-friendly online web server at http://pmlabstack.pythonanywhere.com/StackDPPIV.

UMPred-FRL: A New Approach for Accurate Prediction of Umami Peptides Using Feature Representation Learning

Umami ingredients have been identified as important factors in food seasoning and production. Traditional experimental methods for characterizing peptides exhibiting umami sensory properties (umami peptides) are time-consuming, laborious, and costly. As a result, it is preferable to develop computational tools for the large-scale identification of available sequences in order to identify novel peptides with umami sensory properties. Although a computational tool has been developed for this purpose, its predictive performance is still insufficient. In this study, we use a feature representation learning approach to create a novel machine-learning meta-predictor called UMPred-FRL for improved umami peptide identification. We combined six well-known machine learning algorithms (extremely randomized trees, k-nearest neighbor, logistic regression, partial least squares, random forest, and support vector machine) with seven different feature encodings (amino acid composition, amphiphilic pseudo-amino acid composition, dipeptide composition, composition-transition-distribution, and pseudo-amino acid composition) to develop the final meta-predictor. Extensive experimental results demonstrated that UMPred-FRL was effective and achieved more accurate performance on the benchmark dataset compared to its baseline models, and consistently outperformed the existing method on the independent test dataset. Finally, to aid in the high-throughput identification of umami peptides, the UMPred-FRL web server was established and made freely available online. It is expected that UMPred-FRL will be a powerful tool for the cost-effective large-scale screening of candidate peptides with potential umami sensory properties.

Prediction of Peptide Detectability Based on CapsNet and Convolutional Block Attention Module

According to proteomics technology, as impacted by the complexity of sampling in the experimental process, several problems remain with the reproducibility of mass spectrometry experiments, and the peptide identification and quantitative results continue to be random. Predicting the detectability exhibited by peptides can optimize the mentioned results to be more accurate, so such a prediction is of high research significance. This study builds a novel method to predict the detectability of peptides by complying with the capsule network (CapsNet) and the convolutional block attention module (CBAM). First, the residue conical coordinate (RCC), the amino acid composition (AAC), the dipeptide composition (DPC), and the sequence embedding code (SEC) are extracted as the peptide chain features. Subsequently, these features are divided into the biological feature and sequence feature, and separately inputted into the neural network of CapsNet. Moreover, the attention module CBAM is added to the network to assign weights to channels and spaces, as an attempt to enhance the feature learning and improve the network training effect. To verify the effectiveness of the proposed method, it is compared with some other popular methods. As revealed from the experimentally achieved results, the proposed method outperforms those methods in most performance assessments.

PreTP-EL: prediction of therapeutic peptides based on ensemble learning

Therapeutic peptides are important for understanding the correlation between peptides and their therapeutic diagnostic potential. The therapeutic peptides can be further divided into different types based on therapeutic function sharing different characteristics. Although some computational approaches have been proposed to predict different types of therapeutic peptides, they failed to accurately predict all types of therapeutic peptides. In this study, a predictor called PreTP-EL has been proposed via employing the ensemble learning approach to fuse the different features and machine learning techniques in order to capture the different characteristics of various therapeutic peptides. Experimental results showed that PreTP-EL outperformed other competing methods. Availability and implementation: A user-friendly web-server of PreTP-EL predictor is available at http://bliulab.net/PreTP-EL.

Identifying multi-functional bioactive peptide functions using multi-label deep learning

The bioactive peptide has wide functions, such as lowering blood glucose levels and reducing inflammation. Meanwhile, computational methods such as machine learning are becoming more and more important for peptide functions prediction. Most of the previous studies concentrate on the single-functional bioactive peptides prediction. However, the number of multi-functional peptides is on the increase; therefore, novel computational methods are needed. In this study, we develop a method MLBP (Multi-Label deep learning approach for determining the multi-functionalities of Bioactive Peptides), which can predict multiple functions including anti-cancer, anti-diabetic, anti-hypertensive, anti-inflammatory and anti-microbial simultaneously. MLBP model takes the peptide sequence vector as input to replace the biological and physiochemical features used in other peptides predictors. Using the embedding layer, the dense continuous feature vector is learnt from the sequence vector. Then, we extract convolution features from the feature vector through the convolutional neural network layer and combine with the bidirectional gated recurrent unit layer to improve the prediction performance. The 5-fold cross-validation experiments are conducted on the training dataset, and the results show that Accuracy and Absolute true are 0.695 and 0.685, respectively. On the test dataset, Accuracy and Absolute true of MLBP are 0.709 and 0.697, with 5.0 and 4.7% higher than those of the suboptimum method, respectively. The results indicate MLBP has superior prediction performance on the multi-functional peptides identification. MLBP is available at https://github.com/xialab-ahu/MLBP and http://bioinfo.ahu.edu.cn/MLBP/.

iR5hmcSC: Identifying RNA 5-hydroxymethylcytosine with multiple features based on stacking learning

RNA 5-hydroxymethylcytosine (5hmC) modification is the basis of the translation of genetic information and the biological evolution. The study of its distribution in transcriptome is fundamentally crucial to reveal the biological significance of 5hmC. Biochemical experiments can use a variety of sequencing-based technologies to achieve high-throughput identification of 5hmC; however, they are labor-intensive, time-consuming, as well as expensive. Therefore, it is urgent to develop more effective and feasible computational methods. In this paper, a novel and powerful model called iR5hmcSC is designed for identifying 5hmC. Firstly, we extract the different features by K-mer, Pseudo Structure Status Composition and One-Hot encoding. Subsequently, the combination of chi-square test and logistic regression is utilized as the feature selection method to select the optimal feature sets. And then stacking learning, an ensemble learning method including random forest (RF), extra trees (EX), AdaBoost (Ada), gradient boosting decision tree (GBDT), and support vector machine (SVM), is used to recognize 5hmC and non-5hmC. Finally, 10-fold cross-validation test is performed to evaluate the model. The accuracy reaches 85.27% and 79.92% on benchmark dataset and independent dataset, respectively. The result is better than the state-of-the-art methods, which indicates that our model is a feasible tool to identify 5hmC. The datasets and source code are freely available at https://github.com/HongyanShi026/iR5hmcSC.

Review and comparative analysis of machine learning-based predictors for predicting and analyzing of anti-angiogenic peptides

Cancer is one of the leading causes of death worldwide and underlying this is angiogenesis that represents one of the hallmarks of cancer. Ongoing effort is already under way in the discovery of anti-angiogenic peptides (AAPs) as a promising therapeutic route by tackling the formation of new blood vessels. As such, the identification of AAPs constitutes a viable path for understanding their mechanistic properties pertinent for the discovery of new anti-cancer drugs. In spite of the abundance of peptide sequences in public databases, experimental efforts in the identification of anti-angiogenic peptides have progressed very slowly owing to its high expenditures and laborious nature. Owing to its inherent ability to make sense of large volumes of data, machine learning (ML) represents a lucrative technique that can be harnessed for peptide-based drug discovery. In this review, we conducted a comprehensive and comparative analysis of ML-based AAP predictors in terms of their employed feature descriptors, ML algorithms, cross-validation methods and prediction performance. Moreover, the common framework of these AAP predictors and their inherent weaknesses are also discussed. Particularly, we explore future perspectives for improving the prediction accuracy and model interpretability, which represents an interesting avenue for overcoming some of the inherent weaknesses of existing AAP predictors. We anticipate that this review would assist researchers in the rapid screening and identification of promising AAPs for clinical use.

ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation

Anticancer peptides (ACPs) have provided a promising perspective for cancer treatment, and the prediction of ACPs is very important for the discovery of new cancer treatment drugs. It is time consuming and expensive to use experimental methods to identify ACPs, so computational methods for ACP identification are urgently needed. There have been many effective computational methods, especially machine learning-based methods, proposed for such predictions. Most of the current machine learning methods try to find suitable features or design effective feature learning techniques to accurately represent ACPs. However, the performance of these methods can be further improved for cases with insufficient numbers of samples. In this article, we propose an ACP prediction model called ACP-DA (Data Augmentation), which uses data augmentation for insufficient samples to improve the prediction performance. In our method, to better exploit the information of peptide sequences, peptide sequences are represented by integrating binary profile features and AAindex features, and then the samples in the training set are augmented in the feature space. After data augmentation, the samples are used to train the machine learning model, which is used to predict ACPs. The performance of ACP-DA exceeds that of existing methods, and ACP-DA achieves better performance in the prediction of ACPs compared with a method without data augmentation. The proposed method is available at http://github.com/chenxgscuec/ACPDA.

i4mC-EL: Identifying DNA N4-Methylcytosine Sites in the Mouse Genome Using Ensemble Learning

As one of important epigenetic modifications, DNA N4-methylcytosine (4mC) plays a crucial role in controlling gene replication, expression, cell cycle, DNA replication, and differentiation. The accurate identification of 4mC sites is necessary to understand biological functions. In the paper, we use ensemble learning to develop a model named i4mC-EL to identify 4mC sites in the mouse genome. Firstly, a multifeature encoding scheme consisting of Kmer and EIIP was adopted to describe the DNA sequences. Secondly, on the basis of the multifeature encoding scheme, we developed a stacked ensemble model, in which four machine learning algorithms, namely, BayesNet, NaiveBayes, LibSVM, and Voted Perceptron, were utilized to implement an ensemble of base classifiers that produce intermediate results as input of the metaclassifier, Logistic. The experimental results on the independent test dataset demonstrate that the overall rate of predictive accurate of i4mC-EL is 82.19%, which is better than the existing methods. The user-friendly website implementing i4mC-EL can be accessed freely at the following.

ANOX: A robust computational model for predicting the antioxidant proteins based on multiple features

As an indispensable component of various living organisms, the antioxidant proteins have been studied for anti-aging and prevention of various diseases, such as altitude sickness, coronary heart disease, and even cancer. However, the traditional experimental methods for identifying the antioxidant proteins are very expensive and time-consuming. Thus, to address the challenge, a new predictor, named ANOX, was developed in this study. Multiple features, such as frequency matrix features (FRE), amino acid and dipeptide composition (AADP), evolutionary difference formula features (EEDP), k-separated bigrams (KSB), and PSI-PRED secondary structure (PRED), were extracted to generate the original feature space. To find the optimized feature subset, the Max-Relevance-Max-Distance (MRMD) algorithm was implemented for feature ranking and our model received the best performance with the top 1170 features. Rigorous tests were performed to evaluate the performance of ANOX, and the results showed that ANOX achieved a major improvement in the prediction accuracy of the antioxidant proteins (AUC:0.930 and 0.935 using 5-fold cross-validation or the jackknife test) compared to the state-of-the-art predictor AOPs-SVM (AUC:0.869 and 0.885). The dataset used in this study and the source code of ANOX are all available at https://github.com/NWAFU-LiuLab/ANOX.

i6mA-VC: A Multi-Classifier Voting Method for the Computational Identification of DNA N6-methyladenine Sites

DNA N6-methyladenine (6 mA), as an essential component of epigenetic modification, cannot be neglected in genetic regulation mechanism. The efficient and accurate prediction of 6 mA sites is beneficial to the development of biological genetics. Biochemical experimental methods are considered to be time-consuming and laborious. Most of the established machine learning methods have a single dataset. Although some of them have achieved cross-species prediction, their results are not satisfactory. Therefore, we designed a novel statistical model called i6mA-VC to improve the accuracy for 6 mA sites. On the one hand, kmer and binary encoding are applied to extract features, and then gradient boosting decision tree (GBDT) embedded method is applied as the feature selection strategy. On the other hand, DNA sequences are represented by vectors through the feature extraction method of ring-function-hydrogen-chemical properties (RFHCP) and the feature selection strategy of ExtraTree. After fusing the two optimal features, a voting classifier based on gradient boosting decision tree (GBDT), light gradient boosting machine (LightGBM) and multilayer perceptron classifier (MLPC) is constructed for final classification and prediction. The accuracy of Rice dataset and M.musculus dataset with five-fold cross-validation are 0.888 and 0.967, respectively. The cross-species dataset is selected as independent testing dataset, and the accuracy reaches 0.848. Through rigorous experiments, it is demonstrated that the proposed predictor is convincing and applicable. The development of i6mA-VC predictor will become an effective way for the recognition of N6-methyladenine sites, and it will also be beneficial for biological geneticists to further study gene expression and DNA modification. In addition, an accessible web-server for i6mA-VC is available from http://www.zhanglab.site/ .

iORI-ENST: identifying origin of replication sites based on elastic net and stacking learning

DNA replication is not only the basis of biological inheritance but also the most fundamental process in all living organisms. It plays a crucial role in the cell-division cycle and gene expression regulation. Hence, the accurate identification of the origin of replication sites (ORIs) has a great meaning for further understanding the regulatory mechanism of gene expression and treating genic diseases. In this paper, a novel, feasible and powerful model, namely, iORI-ENST is designed for identifying ORIs. Firstly, we extract the different features by incorporating mono-nucleotide binary encoding and dinucleotide-based spatial autocorrelation. Subsequently, elastic net is utilized as the feature selection method to select the optimal feature set. And then stacking learning is employed to predict ORIs and non-ORIs, which contains random forest, adaboost, gradient boosting decision tree, extra trees and support vector machine. Finally, the ORI sites are identified on the benchmark datasets S1 and S2 with their accuracies of 91.41% and 95.07%, respectively. Meanwhile, an independent dataset S3 is employed to verify the validation and transferability of our model and its accuracy reaches 91.10%. Comparing with state-of-the-art methods, our model achieves more remarkable performance. The results show our model is a feasible, effective and powerful tool for identifying ORIs. The source code and datasets are available at https://github.com/YingyingYao/iORI-ENST.

Prediction of lncRNA-Protein Interactions via the Multiple Information Integration

The long non-coding RNA (lncRNA)-protein interaction plays an important role in the post-transcriptional gene regulation, such as RNA splicing, translation, signaling, and the development of complex diseases. The related research on the prediction of lncRNA-protein interaction relationship is beneficial in the excavation and the discovery of the mechanism of lncRNA function and action occurrence, which are important. Traditional experimental methods for detecting lncRNA-protein interactions are expensive and time-consuming. Therefore, computational methods provide many effective strategies to deal with this problem. In recent years, most computational methods only use the information of the lncRNA-lncRNA or the protein-protein similarity and cannot fully capture all features to identify their interactions. In this paper, we propose a novel computational model for the lncRNA-protein prediction on the basis of machine learning methods. First, a feature method is proposed for representing the information of the network topological properties of lncRNA and protein interactions. The basic composition feature information and evolutionary information based on protein, the lncRNA sequence feature information, and the lncRNA expression profile information are extracted. Finally, the above feature information is fused, and the optimized feature vector is used with the recursive feature elimination algorithm. The optimized feature vectors are input to the support vector machine (SVM) model. Experimental results show that the proposed method has good effectiveness and accuracy in the lncRNA-protein interaction prediction.

Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method

As anticancer peptides (ACPs) have attracted great interest for cancer treatment, several approaches based on machine learning have been proposed for ACP identification. Although existing methods have afforded high prediction accuracies, however such models are using a large number of descriptors together with complex ensemble approaches that consequently leads to low interpretability and thus poses a challenge for biologists and biochemists. Therefore, it is desirable to develop a simple, interpretable and efficient predictor for accurate ACP identification as well as providing the means for the rational design of new anticancer peptides with promising potential for clinical application. Herein, we propose a novel flexible scoring card method (FSCM) making use of propensity scores of local and global sequential information for the development of a sequence-based ACP predictor (named iACP-FSCM) for improving the prediction accuracy and model interpretability. To the best of our knowledge, iACP-FSCM represents the first sequence-based ACP predictor for rationalizing an in-depth understanding into the molecular basis for the enhancement of anticancer activities of peptides via the use of FSCM-derived propensity scores. The independent testing results showed that the iACP-FSCM provided accuracies of 0.825 and 0.910 as evaluated on the main and alternative datasets, respectively. Results from comparative benchmarking demonstrated that iACP-FSCM could outperform seven other existing ACP predictors with marked improvements of 7% and 17% for accuracy and MCC, respectively, on the main dataset. Furthermore, the iACP-FSCM (0.910) achieved very comparable results to that of the state-of-the-art ensemble model AntiCP2.0 (0.920) as evaluated on the alternative dataset. Comparative results demonstrated that iACP-FSCM was the most suitable choice for ACP identification and characterization considering its simplicity, interpretability and generalizability. It is highly anticipated that the iACP-FSCM may be a robust tool for the rapid screening and identification of promising ACPs for clinical use.

IHEC_RAAC: a online platform for identifying human enzyme classes via reduced amino acid cluster strategy

Enzymes have been proven to play considerable roles in disease diagnosis and biological functions. The feature extraction that truly reflects the intrinsic properties of protein is the most critical step for the automatic identification of enzymes. Although lots of feature extraction methods have been proposed, some challenges remain. In this study, we developed a predictor called IHEC_RAAC, which has the capability to identify whether a protein is a human enzyme and distinguish the function of the human enzyme. To improve the feature representation ability, protein sequences were encoded by a new feature-vector called 'reduced amino acid cluster'. We calculated 673 amino acid reduction alphabets to determine the optimal feature representative scheme. The tenfold cross-validation test showed that the accuracy of IHEC_RAAC to identify human enzymes was 74.66% and further discriminate the human enzyme classes with an accuracy of 54.78%, which was 2.06% and 8.68% higher than the state-of-the-art predictors, respectively. Additionally, the results from the independent dataset indicated that IHEC_RAAC can effectively predict human enzymes and human enzyme classes to further provide guidance for protein research. A user-friendly web server, IHEC_RAAC, is freely accessible at http://bioinfor.imu.edu.cn/ihecraac .

ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representation

The peptide therapeutics market is providing new opportunities for the biotechnology and pharmaceutical industries. Therefore, identifying therapeutic peptides and exploring their properties are important. Although several studies have proposed different machine learning methods to predict peptides as being therapeutic peptides, most do not explain the decision factors of model in detail. In this work, an Interpretable Therapeutic Peptide Prediction (ITP-Pred) model based on efficient feature fusion was developed. First, we proposed three kinds of feature descriptors based on sequence and physicochemical property encoded, namely amino acid composition (AAC), group AAC and coding autocorrelation, and concatenated them to obtain the feature representation of therapeutic peptide. Then, we input it into the CNN-Bi-directional Long Short-Term Memory (BiLSTM) model to automatically learn recognition of therapeutic peptides. The cross-validation and independent verification experiments results indicated that ITP-Pred has a higher prediction performance on the benchmark dataset than other comparison methods. Finally, we analyzed the output of the model from two aspects: sequence order and physical and chemical properties, mining important features as guidance for the design of better models that can complement existing methods.